Nathalia Padilla

547 total citations
17 papers, 215 citations indexed

About

Nathalia Padilla is a scholar working on Surgery, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Nathalia Padilla has authored 17 papers receiving a total of 215 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 12 papers in Genetics and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Nathalia Padilla's work include Pancreatic function and diabetes (11 papers), Diabetes and associated disorders (10 papers) and Diabetes Management and Research (5 papers). Nathalia Padilla is often cited by papers focused on Pancreatic function and diabetes (11 papers), Diabetes and associated disorders (10 papers) and Diabetes Management and Research (5 papers). Nathalia Padilla collaborates with scholars based in United States, Italy and Bulgaria. Nathalia Padilla's co-authors include Camillo Ricordi, Rodolfo Alejandro, Andrea Fabbri, Marco Infante, David A. Baidal, Ana Alvarez, Massimiliano Caprio, Janine Sanchez, Michael Clare‐Salzler and Elina Linetsky and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes.

In The Last Decade

Nathalia Padilla

15 papers receiving 207 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathalia Padilla United States 6 105 92 66 59 45 17 215
Joana R. N. Lemos United States 8 19 0.2× 54 0.6× 71 1.1× 64 1.1× 36 0.8× 39 212
Minu George United States 7 63 0.6× 66 0.7× 27 0.4× 104 1.8× 51 1.1× 12 270
N. Lammi Finland 7 29 0.3× 212 2.3× 125 1.9× 197 3.3× 18 0.4× 8 341
E. Tuncel Türkiye 10 71 0.7× 13 0.1× 78 1.2× 88 1.5× 24 0.5× 21 356
Amer Alsaied Qatar 3 121 1.2× 57 0.6× 56 0.8× 20 0.3× 192 4.3× 5 315
Anna Conte Italy 8 32 0.3× 39 0.4× 78 1.2× 39 0.7× 9 0.2× 14 285
Amy R. DeFelice United States 8 18 0.2× 118 1.3× 173 2.6× 11 0.2× 45 1.0× 17 387
Siham Accacha United States 5 33 0.3× 79 0.9× 20 0.3× 56 0.9× 17 0.4× 14 180
Takeshi Arishima Japan 4 36 0.3× 14 0.2× 48 0.7× 195 3.3× 10 0.2× 11 257
Naina Sinha Gregory United States 10 14 0.1× 31 0.3× 38 0.6× 71 1.2× 8 0.2× 12 192

Countries citing papers authored by Nathalia Padilla

Since Specialization
Citations

This map shows the geographic impact of Nathalia Padilla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathalia Padilla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathalia Padilla more than expected).

Fields of papers citing papers by Nathalia Padilla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathalia Padilla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathalia Padilla. The network helps show where Nathalia Padilla may publish in the future.

Co-authorship network of co-authors of Nathalia Padilla

This figure shows the co-authorship network connecting the top 25 collaborators of Nathalia Padilla. A scholar is included among the top collaborators of Nathalia Padilla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathalia Padilla. Nathalia Padilla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Infante, Marco, F Silvestri, Nathalia Padilla, et al.. (2025). Unveiling the Therapeutic Potential of the Second-Generation Incretin Analogs Semaglutide and Tirzepatide in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults. Journal of Clinical Medicine. 14(4). 1303–1303. 3 indexed citations
2.
Padilla, Nathalia, Russka Shumnalieva, David Della‐Morte, et al.. (2025). T helper 17 cells and interleukin-17 immunity in type 1 diabetes: From pathophysiology to targeted immunotherapies. World Journal of Diabetes. 16(4). 99936–99936. 3 indexed citations
3.
Baidal, David A., Ana Alvarez, Nathalia Padilla, et al.. (2025). 12-8: PERSISTENCE OF GRAFT FUNCTION FOLLOWING DISCONTINUATION OF IMMUNOSUPPRESSION IN AN ISLET TRANSPLANT RECIPIENT ON CHRONIC GLP-1 RA THERAPY. Transplantation. 109(6S1). 57–57.
4.
Baidal, David A., Ana Alvarez, Nathalia Padilla, et al.. (2025). 25(OH) Vitamin D Levels and Severity of Type 1 Diabetes in Youth and Adults With Recent-Onset Disease. Journal of the Endocrine Society. 9(6). bvaf061–bvaf061. 1 indexed citations
5.
Lemos, Joana R. N., Raffaella Poggioli, Nujen Çolak Bozkurt, et al.. (2023). Impact of GAD65 and IA2 autoantibodies on islet allograft survival. SHILAP Revista de lepidopterología. 4. 1269758–1269758. 2 indexed citations
6.
Padilla, Nathalia, Andrea Fabbri, David Della‐Morte, Camillo Ricordi, & Marco Infante. (2023). Papel inmunomodulador de la vitamina D y los ácidos grasos poliinsaturados omega-3 en trastornos autoinmunes: Revisión de la Literatura. SHILAP Revista de lepidopterología. 73(3). 223–232. 2 indexed citations
7.
Infante, Marco, Laura Vitiello, Andrea Fabbri, et al.. (2023). Prolonged Clinical Remission of Type 1 Diabetes Sustained by Calcifediol and Low-Dose Basal Insulin: A Case Report. Immunotherapy. 15(13). 1009–1019. 1 indexed citations
8.
Infante, Marco, Nathalia Padilla, Rodolfo Alejandro, et al.. (2022). Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents. Medicina. 58(5). 571–571. 8 indexed citations
9.
Infante, Marco, Andrea Fabbri, Nathalia Padilla, et al.. (2022). BNT162b2 mRNA COVID-19 Vaccine Does Not Impact the Honeymoon Phase in Type 1 Diabetes: A Case Report. Vaccines. 10(7). 1096–1096. 4 indexed citations
10.
Baidal, David A., Joana R. N. Lemos, Stephanie Camhi, et al.. (2021). Long-term Persistence of Allosensitization After Islet Allograft Failure. Transplantation. 105(11). 2490–2498. 5 indexed citations
11.
Baidal, David A., et al.. (2020). 118-OR: HLA Matching and Clinical Outcomes in Islet Transplantation. Diabetes. 69(Supplement_1). 1 indexed citations
12.
Baidal, David A., Dora M. Berman, Camillo Ricordi, et al.. (2019). 259-LB: Stable Graft Function and Glycemic Control after Clinical Islet Transplantation on the Omentum. Diabetes. 68(Supplement_1). 3 indexed citations
13.
Infante, Marco, Camillo Ricordi, Nathalia Padilla, et al.. (2019). The Role of Vitamin D and Omega-3 PUFAs in Islet Transplantation. Nutrients. 11(12). 2937–2937. 25 indexed citations
14.
Infante, Marco, Camillo Ricordi, Janine Sanchez, et al.. (2019). Influence of Vitamin D on Islet Autoimmunity and Beta-Cell Function in Type 1 Diabetes. Nutrients. 11(9). 2185–2185. 145 indexed citations
16.
Baidal, David A., Camillo Ricordi, Dora M. Berman, et al.. (2018). Long-Term Function of Islet Allografts Transplanted on the Omentum Using a Biological Scaffold. Diabetes. 67(Supplement_1). 5 indexed citations
17.
Zoso, Alessia, Paolo Serafini, Giacomo Lanzoni, et al.. (2016). G-CSF and Exenatide Might Be Associated with Increased Long-Term Survival of Allogeneic Pancreatic Islet Grafts. PLoS ONE. 11(6). e0157245–e0157245. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026